Cervical Cancer Prevention

Cancer Screening and Awareness

About Cervical Cancer

Each year, more than 12,000 women are diagnosed with cervical cancer in the United States, and nearly 4,000 die. Most of these deaths could be prevented if women had tests (PAP test) to detect cervical precancer or cancer early. The most important risk factor for developing cervical cancer is persistent infection with a high risk type of Human Papillomavirus (HPV).

HPV is short for Human Papillomavirus, a group of viruses that are transmitted to both males and females through genital contact. These viruses can cause small genital or anal warts (papillomas), as well as changes that can progress to cancer. HPV is the leading cause of cervical cancer and in 2006 the FDA licensed the first vaccine against the virus, which is now recommended for women ages 11 to 26. Since HPV infection is so common, it is important to learn about HPV screening and prevention.

Cervical Cancer Screening at NewYork-Presbyterian

NewYork-Presbyterian provides a comprehensive range of early detection and prevention programs for cervical cancer including pap smears, HPV testing and vaccine, and genetic counseling and testing.

Columbia University Medical Center campus

Department of Obstetrics and Gynecology
Telephone: 212-305-3101
Website: http://www.cumc.columbia.edu/dept/obgyn
Northern Manhattan Cancer Screening Program
Telephone: 212-851-4516
Serves uninsured/underinsured throughout the year by appointment.